Bio-Novumsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-11-09
Share capital
160 000,00 PLN
Activity description

Bio-Novum is a company specializing in medical laboratory diagnostics and biotechnology, providing high-specialty diagnostic tests for healthcare facilities and research institutions. Their product offerings include rapid diagnostic tests, immunochemical tests, and solutions for automating the erythrocyte sedimentation rate (ESR) test, as well as tests for detecting SARS-CoV-2 infections. Additionally, Bio-Novum represents companies from South Korea, the United States, and China in Poland.

Registered address
ul. Nowy Świat 23A/3u, 20-418 Lublin, Poland
Website
bio-novum.comWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-47211-22183-JBEWR-22

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 3.46mMedianUSD 874.89kAverageUSD 20.29m
Net profit
This companyUSD 649.39kMedianUSD 28.28kAverageUSD 815.91k
Operating costs
This companyUSD 2.71mMedianUSD 806.30kAverageUSD 19.08m
Assets
This companyUSD 2.25mMedianUSD 541.70kAverageUSD 10.94m

Bank accounts

Registered as a VAT taxpayer on 2018-11-16. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

13 public aid cases recorded, with a total value of $220,190.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,960
Aid for microenterprises in the form of public interventions concerning electricity, gas or heat supplies
$63
De minimis aid (in accordance with Commission Regulation 2023/2831)
$4,241

European Funds

ProjectEU co-financing
Rozwój działalności i umiędzynarodowienie Bio-Novum Sp. z o. o.
$34,267
Bio-Novum Sp. z o. o. na rynkach zagranicznych.
$32,707
Internacjonalizacja oferty firmy Bio-Novum Sp. z o.o.
$131.6K

Tenders

181 tenders recorded as contractor: 120 national ($2,533,611) and 61 EU ($38,773,446).

SubjectAmount
„Zakup i dostawa odczynników chemicznych wraz z akcesoriami oraz dzierżawy analizatorów”
–
Dostawa odczynników i sprzętu laboratoryjnego II
–
Dostawa odczynników i akcesoriów do diagnostyki laboratoryjnej wraz z dzierżawą odpowiednich urządzeń
–

Public sector contracts

Bio-Novum is the contractor in 45 public sector contracts, worth PLN 619.10k in total. They were signed with 37 public buyers. The largest number (2) were signed with Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie.

Public buyerValue
Wojewódzki Szpital Podkarpacki Im. Jana Pawła II w KrośniePLN 10,950
Szpital Wojewódzki Im. Jana Pawła II w BełchatowiePLN 626.40
Samodzielny Publiczny Zakład Opieki Zdrowotnej w KraśnikuPLN 920.00
Samodzielny Publiczny Zakład Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny Nr 1 Im. Norberta Barlickiego Uniwersytetu Medycznego w ŁodziPLN 38,350
Zakład Karny w CzarnemPLN 533.33

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Piotr Adam Rubaj – Management Board Member
Artur Marcin Golus – Management Board Member

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Artur Marcin Golus (42)
79$21,339.8249.375%
Piotr Adam Rubaj (58)
80$21,609.9450%
Others
1$270.120.625%

Beneficial owners

Person

Competitors

Name
Eclipse Boluk-Sobolewskasp. k.
Novama CloudS.A.
Diather Petrusewiczsp. k.
Animalabsp. z o.o.
Sanlab J. Kaczorek, M. Bińczaksp. j.
Pohl & Pohlsp. z o.o.
Farmbudsp. z o.o.
Genoplast BiotechS.A.
CryoprofilS.A.
Optimed Pro-Office Cirrosp. j.

Change history

DateEvent
2021-05-06Address change
2021-02-15Share capital change
2018-11-09Entered in the register

FAQ

Last updated: 2026-06-25